Psychemedics Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMD research report →
Companywww.psychemedics.com
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time.
- CEO
- Brian Hullinger
- IPO
- 1987
- Employees
- 116
- HQ
- Acton, MA, US
Price Chart
Valuation
- Market Cap
- $15.56M
- P/E
- -8.42
- P/S
- 0.79
- P/B
- 3.05
- EV/EBITDA
- 80.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 36.07%
- Op Margin
- -9.62%
- Net Margin
- -9.45%
- ROE
- -31.54%
- ROIC
- -29.20%
Growth & Income
- Revenue
- $19.68M · -10.92%
- Net Income
- $-1,861,000 · 55.20%
- EPS
- $-0.32 · 55.56%
- Op Income
- $-1,893,000
- FCF YoY
- 151.44%
Performance & Tape
- 52W High
- $2.67
- 52W Low
- $2.60
- 50D MA
- $2.10
- 200D MA
- $2.23
- Beta
- 0.67
- Avg Volume
- 31.05K
Get TickerSpark's AI analysis on PMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 17, 24 | Powell Anderson Capital Partners LLC | buy | 9,850 |
| Dec 16, 24 | Powell Anderson Capital Partners LLC | buy | 30,000 |
| Dec 13, 24 | Powell Anderson Capital Partners LLC | buy | 80,000 |
| Dec 17, 24 | Powell Anderson Capital Partners LLC | buy | 9,850 |
| Dec 16, 24 | Powell Anderson Capital Partners LLC | buy | 30,000 |
| Dec 12, 24 | Powell Anderson Capital Partners LLC | buy | 75,000 |
| Dec 11, 24 | Powell Anderson Capital Partners LLC | buy | 4,518 |
| Dec 10, 24 | Powell Anderson Capital Partners LLC | buy | 7,473 |
| Dec 10, 24 | Kamin Peter | sell | 320,708 |
| Dec 4, 24 | Powell Anderson Capital Partners LLC | other | 0 |
Our PMD Coverage
We haven't published any research on PMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PMD Report →